This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

PASSION FOR PRECISION

Delivering the promise of radiopharmaceuticals 
to patients.

Our Mission

We aim to provide the most precise cancer radiodiagnostics and therapeutics to fight hard-to-treat tumors. We are leveraging our
radioisotope leadership to build a broad precision oncology pipeline to improve clinical outcomes and quality of life for patients living with cancer.

Latest News

See all →

ITM and TerThera Sign Supply Agreement for Medical Radioisotope Terbium-161

Garching / Munich, Germany, and Breda, the Netherlands, September 24, 2025 - ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical…

Read more

ITM to Present COMPETE Dosimetry Data and Host Satellite Symposium at EANM 2025

Garching / Munich, Germany, September 16, 2025 -ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today…

Read more

Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225

Florham Park, New Jersey, USA and Garching / Munich, Germany, September 11, 2025 – Cellectar Biosciences, Inc. (Nasdaq: CLRB, “Cellectar”), a…

Read more

ITM has one of the deepest, broadest clinical RPT pipelines

Pipeline

Global supply of targeted diagnostic and therapeutic radiopharmaceuticals

Read more about us

Delivering the Promise of Radiopharmaceuticals to Patients

Read more about us

Precision Diagnostics and Therapeutics

Pipeline

Your Career at ITM - Precisely for You

Read more about us